Here's the live share price of Pharmaids Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Pharmaids Pharmaceuticals has gained 68.89% CAGR. Over the past year, the corresponding return has been 38.50%.
Pharmaids Pharmaceuticals’s current P/E of -15.87x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Pharmaids Pharmaceuticals | -3.15 | -5.92 | 0.41 | -16.11 | 39.79 | 62.91 | 68.89 |
Sun Pharmaceutical Industries | 0.46 | -1.83 | -4.93 | -6.07 | -13.98 | 21.68 | 26.44 |
Divi's Laboratories | 0.68 | -2.03 | -9.69 | 6.55 | 10.26 | 18 | 13.79 |
Cipla | -0.18 | -0.98 | 1.45 | 3.75 | -6.67 | 13.52 | 16.5 |
Torrent Pharmaceuticals | -3.05 | -3.34 | 7.71 | 15.39 | 2.27 | 32.67 | 20.35 |
Dr. Reddy's Laboratories | 0.65 | 3.01 | -3.33 | 13.16 | -2.09 | 15.26 | 8.32 |
Mankind Pharma | -0.41 | 4.42 | 8.91 | 18.73 | 4.99 | 21.89 | 12.61 |
Zydus Lifesciences | 0 | 5.08 | 6.44 | 16.05 | -7.08 | 40.26 | 22.98 |
Lupin | 4.49 | 3.93 | 1.81 | 2.8 | -9.12 | 44.83 | 16.16 |
Abbott India | 1.08 | -5.07 | -2.16 | 2.66 | 6.29 | 19.99 | 13.39 |
Alkem Laboratories | 3 | 2.66 | 12.83 | 14.01 | -13.62 | 19.58 | 13.54 |
Aurobindo Pharma | 5.23 | 0.79 | -3.96 | -1.28 | -29.67 | 25.72 | 6.67 |
Glenmark Pharmaceuticals | -0.85 | 6.28 | 24.71 | 46.64 | 20.47 | 74.71 | 34.18 |
Laurus Labs | -0.7 | 3.54 | 31.78 | 54.09 | 77.57 | 17.47 | 27.44 |
Biocon | -1.7 | -1.58 | 0.32 | 7.35 | -8.27 | 5.74 | -3.58 |
Anthem Biosciences | 1.94 | 4.25 | 14.29 | 14.29 | 14.29 | 4.55 | 2.71 |
GlaxoSmithKline Pharmaceuticals | -2.35 | -1.35 | -18.25 | 2.21 | -2.76 | 24.76 | 9.75 |
Cohance Lifesciences | -3.42 | 9.49 | -0.98 | -13.33 | -15.99 | 26.86 | 22.11 |
Ipca Laboratories | -0.43 | -5.15 | -3.58 | -0.16 | -9.98 | 13.54 | 4.09 |
Gland Pharma | 4.52 | 1.75 | 13.4 | 29.15 | 7.54 | -6.26 | 1.96 |
Over the last one year, Pharmaids Pharmaceuticals has gained 39.79% compared to peers like Sun Pharmaceutical Industries (-13.98%), Divi's Laboratories (10.26%), Cipla (-6.67%). From a 5 year perspective, Pharmaids Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (26.44%) and Divi's Laboratories (13.79%).
Day | SMA | EMA |
---|---|---|
5 | 60.52 | 59.38 |
10 | 60.9 | 60.23 |
20 | 61.53 | 61.09 |
50 | 62.46 | 61.9 |
100 | 62.45 | 62.55 |
200 | 65.46 | 61.83 |
In the latest quarter, Pharmaids Pharmaceuticals saw a drop in promoter holding to 5.14%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 94.87% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 07, 2025, 4:22 AM IST | Pharmaids Pharma - Announcement Under Regulation 30 - Intimation Of Registration Of Sale Deed. |
Aug 29, 2025, 11:43 PM IST | Pharmaids Pharma - Reg. 34 (1) Annual Report. |
Aug 29, 2025, 11:41 PM IST | Pharmaids Pharma - Notice Of Convening The 36Th Annual General Meeting |
Aug 29, 2025, 10:50 PM IST | Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Open Offer - Updates |
Aug 29, 2025, 5:39 AM IST | Pharmaids Pharma - Post Offer Advertisement |
Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 2.34 Cr. and Equity Capital is Rs. 35.27 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Pharmaids Pharmaceuticals is ₹58.67 as on Sep 15, 2025.
The Pharmaids Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Pharmaids Pharmaceuticals is ₹206.92 Cr as on Sep 15, 2025.
Today’s highest and lowest price of Pharmaids Pharmaceuticals are ₹60.99 and ₹57.00.
The 52-week high/low is the highest and lowest price at which Pharmaids Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Pharmaids Pharmaceuticals is ₹87.46 and 52-week low of Pharmaids Pharmaceuticals is ₹31.90 as on Sep 15, 2025.
The Pharmaids Pharmaceuticals has shown returns of 1.59% over the past day, -7.11% for the past month, 1.22% over 3 months, 38.5% over 1 year, 62.91% across 3 years, and 68.89% over 5 years.
P/E ratio of and PB ratio of Pharmaids Pharmaceuticals are -15.87 and 3.08 on Sep 15, 2025. While the company gives a dividend yield of 0.00 per annum.